
The Cost Of A Cure: Patent Rights And Drug Prices
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs.
Position your firm for long-term growth with better financial visibility and control. Learn how to track performance, manage spending, and plan strategically—download the full e-book now.